United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Genentech gets Kadcyla FDA approval for post-surgery treatment of HER2+ EBC Kadcyla FDA approval : Roche subsidiary Genentech has secured approval from the US Food and Drug Administration (FDA)… bypharmanewsdailyMay 5, 2019
